PRESS RELEASE: Released on 2007-11-13 12:19 IMMUNOTEC INC.

– HEALTH CANADA APPROVES HEALTH CLAIM FOR HMS 90 / IMMUNOCAL Montreal, Quebec, Tuesday, November 13, 2007 Immunotec Inc. (TSX-V IMM) announces that it has received regulatory approval from Health Canada to market HMS 90 / IMMUNOCAL with the following health claim: “a natural source of the glutathione precursor cysteine for the maintenance of a strong immune system.” The Natural Health Products Directorate (NHPD) is Health Canada’s division responsible for the evaluation of the safety, efficacy and quality of natural health products. It has issued a Natural Product Number (NPN) for HMS 90 / IMMUNOCAL based on the credibility, strength and quality of evidence provided to support the claim. Immunotec strongly supports the implementation of the Natural Health Products Regulation. President and Chief Executive Officer Jim Northrop notes: “The imposition of high standards to ensure the quality, safety and efficacy of natural products supports Immunotec’s commitment to excellence in product development and manufacturing. The issuance of this NPN reinforces to consumers and Distributors alike that superb scientific evidence is the foundation for HMS 90 / IMMUNOCAL. This fact, along with the important associated health claim could have a significant impact on Immunotec’s business growth.” Senior Vice-President, Research & Development, Dr. Wulf Dröge, is extremely pleased about this regulatory approval. “What consumers have known for quite some time has now been formally recognized by the NHPD: the health benefits of Immunotec’s lead product HMS 90 / IMMUNOCAL for the immune system are based on solid science.” Natural Health Products must be manufactured, packaged, and labelled in Health Canadaapproved facilities according to current Good Manufacturing Practices to ensure optimal quality of the finished goods. The evaluation of the efficacy of a specific product allows consumers to make an informed choice when including natural health products in their wellness regimes.
About Immunotec Immunotec operates out of a 37,000 square foot facility located in Vaudreuil-Dorion, Quebec, Canada as well as a distribution centre located in Swanton, Vermont, USA. Immunotec is engaged primarily in the development and marketing of natural health products, dietary supplements, food, vitamins and personal care products, many of which are manufactured on its behalf by third parties. Immunotec’s products are distributed and sold in Canada and the United States through a network marketing system and in other countries under exclusive distributorship agreements. -30Media contact: Richard Patte Executive Vice-President 450 510-4445

Sign up to vote on this title
UsefulNot useful